89 related articles for article (PubMed ID: 8914932)
1. Competition between plasminogen and procathepsin B as a probe to demonstrate the in vitro activation of procathepsin B by the tissue plasminogen activator.
Dalet-Fumeron V; Boudjennah L; Pagano M
Arch Biochem Biophys; 1996 Nov; 335(2):351-7. PubMed ID: 8914932
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor type 2 inhibits cell surface associated tissue plasminogen activator in vitro: potential receptor interactions.
Lobov S; Croucher DR; Saunders DN; Ranson M
Thromb Haemost; 2008 Aug; 100(2):319-29. PubMed ID: 18690354
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase.
Burnett D; Abrahamson M; Devalia JL; Sapsford RJ; Davies RJ; Buttle DJ
Arch Biochem Biophys; 1995 Feb; 317(1):305-10. PubMed ID: 7872798
[TBL] [Abstract][Full Text] [Related]
4. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms.
Johnsen LB; Ravn P; Berglund L; Petersen TE; Rasmussen LK; Heegaard CW; Rasmussen JT; Benfeldt C; Fedosov SN
Biochemistry; 1998 Sep; 37(36):12631-9. PubMed ID: 9730836
[TBL] [Abstract][Full Text] [Related]
5. In vitro activation of pro-cathepsin B by three serine proteinases: leucocyte elastase, cathepsin G, and the urokinase-type plasminogen activator.
Dalet-Fumeron V; Guinec N; Pagano M
FEBS Lett; 1993 Oct; 332(3):251-4. PubMed ID: 8405467
[TBL] [Abstract][Full Text] [Related]
6. Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions.
Caglic D; Pungercar JR; Pejler G; Turk V; Turk B
J Biol Chem; 2007 Nov; 282(45):33076-85. PubMed ID: 17726009
[TBL] [Abstract][Full Text] [Related]
7. [Cathepsin B and pro-drug activation].
Warwas M
Postepy Hig Med Dosw; 2003; 57(6):701-12. PubMed ID: 15002165
[TBL] [Abstract][Full Text] [Related]
8. Activation of procathepsin B in human hepatoma cells: the conversion into the mature enzyme relies on the action of cathepsin B itself.
Mach L; Schwihla H; Stüwe K; Rowan AD; Mort JS; Glössl J
Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):437-42. PubMed ID: 8393661
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of human procathepsin K.
LaLonde JM; Zhao B; Janson CA; D'Alessio KJ; McQueney MS; Orsini MJ; Debouck CM; Smith WW
Biochemistry; 1999 Jan; 38(3):862-9. PubMed ID: 9893980
[TBL] [Abstract][Full Text] [Related]
10. Maturation of human procathepsin B. Proenzyme activation and proteolytic processing of the precursor to the mature proteinase, in vitro, are primarily unimolecular processes.
Mach L; Mort JS; Glössl J
J Biol Chem; 1994 Apr; 269(17):13030-5. PubMed ID: 8175723
[TBL] [Abstract][Full Text] [Related]
11. Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush.
Siconolfi LB; Seeds NW
J Neurosci Res; 2003 Nov; 74(3):430-4. PubMed ID: 14598319
[TBL] [Abstract][Full Text] [Related]
12. Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D.
van der Stappen JW; Williams AC; Maciewicz RA; Paraskeva C
Int J Cancer; 1996 Aug; 67(4):547-54. PubMed ID: 8759615
[TBL] [Abstract][Full Text] [Related]
13. The occluding loop in cathepsin B defines the pH dependence of inhibition by its propeptide.
Quraishi O; Nägler DK; Fox T; Sivaraman J; Cygler M; Mort JS; Storer AC
Biochemistry; 1999 Apr; 38(16):5017-23. PubMed ID: 10213604
[TBL] [Abstract][Full Text] [Related]
14. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
15. Limited proteolysis of rabbit cardiac procathepsin D in a cell-free system.
Smarel AM; Worobec SW; Ferguson AG; Decker RS; Lesch M
Am J Physiol; 1986 Apr; 250(4 Pt 1):C589-96. PubMed ID: 3963172
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans.
Vasiljeva O; Dolinar M; Pungercar JR; Turk V; Turk B
FEBS Lett; 2005 Feb; 579(5):1285-90. PubMed ID: 15710427
[TBL] [Abstract][Full Text] [Related]
17. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator.
Bell J; Duhon S; Doctor VM
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):229-34. PubMed ID: 12695744
[TBL] [Abstract][Full Text] [Related]
18. Chondroitin sulfate proteoglycan is a potent enhancer in the processing of procathepsin L.
Kihara M; Kakegawa H; Matano Y; Murata E; Tsuge H; Kido H; Katunuma N
Biol Chem; 2002 Dec; 383(12):1925-9. PubMed ID: 12553729
[TBL] [Abstract][Full Text] [Related]
19. Denatured proteins as cofactors for plasminogen activation.
Machovich R; Owen WG
Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-beta-stimulated plasminogen activation by tissue-type plasminogen activator results in processing of neuroendocrine factors.
Kranenburg O; Gent YY; Romijn EP; Voest EE; Heck AJ; Gebbink MF
Neuroscience; 2005; 131(4):877-86. PubMed ID: 15749342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
